Indications and Purposes
| 1 Indications And Usage Libtayo Is Indicated For The Treatment Of Patients With Metastatic Cutaneous Squamous Cell Carcinoma (Mcscc) Or Locally Advanced Cscc (Lacscc) Who Are Not Candidates For Curative Surgery Or Curative Radiation. Libtayo Is A Programmed Death Receptor-1 (Pd-1) Blocking Antibody Indicated For The Treatment Of Patients With Metastatic Cutaneous Squamous Cell Carcinoma (Mcscc) Or Locally Advanced Cscc (Lacscc) Who Are Not Candidates For Curative Surgery Or Curative Radiation. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Cemiplimab |